SENP5 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL485276	0.46	19/20
SCHEMBL4604537	0.60	18/20
SCHEMBL485085	0.58	18/20
SCHEMBL485651	0.57	18/20
SCHEMBL4632932	0.52	18/20
SCHEMBL4604692	0.50	18/20
SCHEMBL9219768	0.50	18/20
SCHEMBL484955	0.47	18/20
SCHEMBL485732	0.46	18/20
SCHEMBL485260	0.56	17/20
SCHEMBL485298	0.56	17/20
SCHEMBL9595149	0.56	17/20
SCHEMBL9374999	0.53	17/20
SCHEMBL9213589	0.52	17/20
SCHEMBL4604734	0.50	17/20
SCHEMBL485661	0.47	17/20
SCHEMBL4604976	0.63	16/20
Hydrochloric Acid (SCHEMBL9304232)	0.60	16/20
SCHEMBL485458	0.59	16/20
SCHEMBL4634951	0.58	16/20

Clinical trials — most relevant to SENP5 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease	PHASE4	UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck	PHASE1	COMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis	nan	UNKNOWN
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases	nan	UNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Apoptosis Markers in Aggressive Periodontitis	nan	COMPLETED
Autophagy Bladder Cancer	nan	UNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing	nan	RECRUITING
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study	nan	COMPLETED
Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma	nan	UNKNOWN
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure	nan	RECRUITING
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas	nan	RECRUITING
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors	nan	NOT_YET_RECRUITING
Next Generation Sequencing in Intrahepatic Cholangiocarcinoma	nan	UNKNOWN
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma	nan	COMPLETED
Genetic Determinants of Sudden Cardiac Death	nan	COMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA	nan	RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma	nan	NOT_YET_RECRUITING
Circulating Markers for Ischemic Heart Disease	nan	RECRUITING
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)	nan	COMPLETED
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage	nan	ENROLLING_BY_INVITATION
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure	nan	COMPLETED
Long Term Prediction of MASH-related HCC Risk by Proteomics	nan	NOT_YET_RECRUITING
PCD New Gene Discovery	nan	COMPLETED
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia	nan	UNKNOWN
The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human	nan	UNKNOWN
Identification of New FTLD Genes	nan	UNKNOWN
Chromosome 5Q Gene Variants and Asthma-Related Traits	nan	COMPLETED
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures	nan	NOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a SENP5 binder may also engage these)

Protein	Name	Similarity
Q8WP32	—	1.000	Q8WP32 →
Q6NXL6	—	1.000	Q6NXL6 →
Q3V089	—	0.994	Q3V089 →
Q86XD8	—	0.993	Q86XD8 →
A2AKX3	—	0.993	A2AKX3 →
A1YFX5	—	0.992	A1YFX5 →
Q28DZ0	—	0.992	Q28DZ0 →
E1BC15	—	0.992	E1BC15 →
F1M5M3	—	0.991	F1M5M3 →
Q8N7Z5	—	0.991	Q8N7Z5 →
Q8C0P0	—	0.991	Q8C0P0 →
Q5VWN6	—	0.991	Q5VWN6 →
A4IGL8	—	0.991	A4IGL8 →
Q90ZS6	—	0.991	Q90ZS6 →
Q9D350	—	0.991	Q9D350 →
Q69554	—	0.991	Q69554 →
P46200	—	0.990	P46200 →
P10244	—	0.990	P10244 →
Q92628	—	0.990	Q92628 →
Q6AXY9	—	0.990	Q6AXY9 →
Q7Z333	—	0.990	Q7Z333 →
Q8BJS8	—	0.990	Q8BJS8 →
CDCA2	Cell division cycle-associated protein 2	0.990	landscape →
Q6KAQ7	—	0.990	Q6KAQ7 →
A2T7G6	—	0.990	A2T7G6 →
Q4V7J0	—	0.990	Q4V7J0 →
Q5DW34	—	0.990	Q5DW34 →
Q0VAV2	—	0.990	Q0VAV2 →
P56716	—	0.990	P56716 →
Q9D4V4	—	0.990	Q9D4V4 →